The Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vacine in Adults with Previous Smallpox Vaccination. A Ramdomized, Double-Blind, Fixed Dose, Phase 3 Comparison between ACAM2000 and Dryvax Smallpox Vaccines

Grants and Contracts Details

StatusFinished
Effective start/end date2/5/0411/30/07

Funding

  • PPD Development: $175,451.00